What does ICON invest in?
ICON invests most often at Series C and Seed (75% of the rounds on record), in sectors such as Biopharma, Biotechnology and Medical.
1 cheques in the last 12 months
Mostly Series C and Seed: 75% of its rounds
Every round we can evidence, newest first6 appearances
1 round
1 round
1 round
3 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Acquisitions by the firm itself
The investors most often in the same rounds as ICON. A count of rooms they were both in, not a relationship either has claimed.
The latest companies ICON put money into.
ICON invests most often at Series C and Seed (75% of the rounds on record), in sectors such as Biopharma, Biotechnology and Medical.
6 investments on record, 1 of them in the last 12 months. The most recent was in Apr 2026.
Its most recent investments on record: Copperhelm (Seed, Apr 2026), Alation (Series C, Jan 2019) and Exabeam (Series D, Aug 2018).
The median round it joins is $40M.
Rarely, if at all: none of its 6 investments on record names it as the lead.
Most of the companies it backs are in the United States (83%) and Israel (17%).
Yes: it is actively investing, with 1 investments in the last 12 months.
Most often SVB Capital (2 rounds together) and Shlomo Kramer (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it